col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


147 Results       Page 1

 [1] 
Wiley: Journal of Internal Medicine
  original article Date Title Authors   All Authors
1 [GO] 2024―Jul―29 SARS-CoV-2 spike protein acts as a β-adrenergic receptor agonist: A potential mechanism for cardiac sequelae of long COVID Xiangning Deng, Hongtu Cui, Hao Liang, Xinyu Wang, Haiyi Yu, Jingjia Wang, et al. (+6)
2 [GO] 2024―Jul―19 Why does severe acute respiratory syndrome coronavirus 2 attack the aged more severely? Yiwen Xie, Hongcui Cao
3 [GO] 2024―Jul―16 High viral loads combined with inflammatory markers predict disease severity in hospitalized COVID-19 patients: Results from the NOR-Solidarity trial Hans-Kittil Viermyr, Bente Halvorsen, Ellen Lund Sagen, Annika E Michelsen, Andreas Barrat-Due, Trine Kåsine, et al. (+10)
4 [GO] 2024―Mar―28 Escalated complement activation during hospitalization is associated with higher risk of 60-day mortality in SARS-CoV-2-infected patients Andreas Barratt-Due, Kristin Pettersen, Tuva Børresdatter-Dahl, Jan Cato Holter, Renathe H. Grønli, Anne Ma Dyrhol-Riise, et al. (+14)
5 [GO] 2023―Dec―31 Only as strong as the weakest link: Adrenal insufficiency in the COVID-19 storm Valeria Hasenmajer
6 [GO] 2023―Dec―13 Smells like a variant: How the association between COVID-19 and olfactory dysfunction changed between 2019 and 2022 Daniel D. DiLena, E. Margaret Warton, David R. Vinson, Marcos H. Siqueiros, Adina S. Rauchwerger, Dustin G. Mark, et al. (+5)
7 [GO] 2023―Nov―29 Vagus nerve SARS-CoV-2 infection and inflammatory reflex dysfunction: Is there a causal relationship? Ulf Andersson, Kevin J. Tracey
8 [GO] 2023―Oct―18 Increased risk of hospitalization, intensive care and death due to COVID-19 in patients with adrenal insufficiency: A Swedish nationwide study Ragnhildur Bergthorsdottir, Daniela Esposito, Daniel S Olsson, Oskar Ragnarsson, Per Dahlqvist, Sophie Bensing, et al. (+3)
9 [GO] 2023―Oct―18 SARS-CoV-2 infection correlates with male benign prostatic hyperplasia deterioration Alex Qinyang Liu, Peter Ka-Fung Chiu, Samuel Chi-Hang Yee, Chi-Fai Ng, Jeremy Yuen-Chun Teoh
10 [GO] 2023―Sep―18 Circulating markers of extracellular matrix remodelling in severe COVID-19 patients Sarah Louise Murphy, Bente Halvorsen, Jan Cato Holter, Camilla Huse, Anders Tveita, Marius Trøseid, et al. (+18)
11 [GO] 2023―Aug―18 UDCA treatment against COVID-19: Do we have enough clinical evidence for drug repurposing? Luisa Ojeda-Fernández, Marta Baviera, Giulia Macaluso, Simone Schena, Mauro Tettamanti, Massimo Cartabia, et al. (+5)
12 [GO] 2023―Jul―31 Incidence and determinants of venous thromboembolism over 90 days in hospitalized and nonhospitalized patients with COVID-19 Birgitte Tholin, Waleed Ghanima, Maria Lie Selle, Knut Stavem
13 [GO] 2023―Jul―20 Ursodeoxycholic acid for coronavirus disease 2019 prevention Kazuya Okushin, Makoto Kurano, Yutaka Yatomi, Kyoji Moriya, Mitsuhiro Fujishiro, Takeya Tsutsumi
14 [GO] 2023―Jul―10 Sociodemographic disparities affect COVID-19 vaccine uptake in non-elderly adults with increased risk of severe COVID-19 Pontus Hedberg, Adonis Sotoodeh, Helena H. Askling, Pontus Nauclér
15 [GO] 2023―Jun―18 Readmission and in-hospital death one year after COVID-19 hospitalization in South Africa Reitze Rodseth, Caroline Maslo, Anchen Laubscher, Richard Friedland
16 [GO] 2023―May―25 Impaired ACE2 glycosylation and protease activity in Fabry disease protects from COVID-19 Ilaria Caputo, Giovanni Bertoldi, Giulia Driussi, Luca Sgarabotto, Gianni Carraro, Lucia Federica Stefanelli, et al. (+2)
17 [GO] 2023―Apr―28 Effective prognostic and clinical risk stratification in COVID-19 using multimodality biomarkers Alexander Liu, Robert Hammond, Peter D Donnelly, Juan Carlos Kaski, Anthony RM Coates
18 [GO] 2023―Apr―25 HIV-related mortality in the United States during the COVID-19 pandemic: A population-based study Xinyuan He, Fan Lv, Marissa Fox, Yee Hui Yeo, Biyao Zou, Jinli Liu, et al. (+6)
19 [GO] 2023―Apr―11 Residual pulmonary infiltrates, symptoms and diffusion impairment at one-year after severe COVID-19 infection have different associated factors Rosario Menéndez, Raúl Méndez, Ana Latorre, Paula González-Jiménez, Germán Peces-Barba, María Molina, et al. (+20)
20 [GO] 2023―Apr―07 SARS-CoV-2 antibody dynamics over time and risk factors associated with infection and long COVID-19 symptoms in large working environments Cecilie Bo Hansen, Kristina Dvoncova, Laura Pérez-Alós, Kamille Fogh, Johannes Roth Madsen, Caroline Hartwell Garred, et al. (+10)
21 [GO] 2023―Apr―05 Ursodeoxycholic acid is associated with a reduction in SARS-CoV-2 infection and reduced severity of COVID-19 in patients with cirrhosis Binu V. John, Dustin Bastaich, Gwilym Webb, Teresa Brevini, Andrew Moon, Raphaella D. Ferreira, et al. (+9)
22 [GO] 2023―Apr―02 Authors reply: Evaluation of SARS-CoV-2 antibody levels on hospital admission as a correlate of protection against mortality Sylvia Mink, Christoph H. Saely, Heinz Drexel, Peter Fraunberger
23 [GO] 2023―Apr―02 Regarding: Evaluation of SARS-CoV-2 antibody levels on hospital admission as a correlate of protection against mortality Shan Song
24 [GO] 2023―Mar―12 Human genetic and immunological determinants of SARS-CoV-2 and Epstein-Barr virus diseases in childhood: Insightful contrasts Qiang Pan-Hammarström, Jean-Laurent Casanova
25 [GO] 2023―Mar―08 Improving hospital outcomes using an acute hospital rehabilitation intensive service (ARISE) for patients with COVID-19 Erik H. Hoyer, Sowmya Kumble, April Pruski, Kelly N. Daley, Nicole Langton-Frost, Bhavesh Patel, et al. (+4)
26 [GO] 2023―Feb―23 Risk factors for impaired respiratory function post COVID-19: A prospective cohort study of nonhospitalized and hospitalized patients Tove Björsell, Josefin Sundh, Anna Lange, Clas Ahlm, Mattias N.E. Forsell, Staffan Tevell, et al. (+4)
27 [GO] 2023―Feb―05 SARS-CoV-2 antibody titers at the time of hospital admission and risk for mortality Hans-Gustaf Ljunggren
28 [GO] 2023―Jan―22 Evaluation of SARS-CoV-2 antibody levels on hospital admission as a correlate of protection against mortality Sylvia Mink, Wolfgang List, Guenter Hoefle, Matthias Frick, Alois Suessenbacher, Thomas Winder, et al. (+5)
29 [GO] 2023―Jan―17 The long and winding road of COVID-19 in survivors of hospitalization Murilo Bacchini Dias, Thiago J. Avelino-Silva, Márlon Juliano Romero Aliberti
30 [GO] 2023―Jan―13 Regarding: The long and winding road of COVID-19 in survivors of hospitalization Oscar M P Jolobe
31 [GO] 2023―Jan―10 Long-term durability of antibody responses after SARS-CoV-2 vaccination and influencing factors Joseph E. Ebinger, Sandy Y. Joung, Minhao Wang, Yunxian Liu, John C. Prostko, Edwin C. Frias, et al. (+8)
32 [GO] 2022―Dec―07 Post COVID-19 condition diagnosis: A population-based cohort study of occurrence, associated factors, and healthcare use by severity of acute infection Pontus Hedberg, Fredrik Granath, Judith Bruchfeld, Johan Askling, Daniel Sjöholm, Michael Fored, et al. (+2)
33 [GO] 2022―Nov―28 Regarding: Factors associated with severe or fatal clinical manifestations of SARS-CoV-2 infection after receiving the third dose of vaccine Oscar Jolobe
34 [GO] 2022―Nov―16 The role of extracellular histones in COVID-19 Femke de Vries, Joram Huckriede, Kanin Wichapong, Chris Reutelingsperger, Gerry A.F. Nicolaes
35 [GO] 2022―Nov―14 A population-based, retrospective cohort study of the association between ABO blood group and risk of COVID-19 Torsten Dahlén, Huiqi Li, Fredrik Nyberg, Gustaf Edgren
36 [GO] 2022―Nov―01 The long and winding road of COVID-19 in survivors of hospitalisation: Symptoms trajectory and predictors of long COVID Murilo Bacchini Dias, Ana Paula Valeriano Medeiros, Sarah Santos de Melo, Cecilia Sella Fonseca, Wilson Jacob-Filho, Thiago J. Avelino-Silva, Márlon Juliano Romero Aliberti
37 [GO] 2022―Aug―24 Prevalence and 24-month recovery of olfactory dysfunction in COVID-19 patients: A multicenter prospective study Jerome R. Lechien, Luigi A. Vaira, Sven Saussez
38 [GO] 2022―Aug―23 Respiratory and systemic monocytes, dendritic cells and myeloid-derived suppressor cells in COVID-19: Implications for disease severity Sara Falck-Jones, Björn Österberg, Anna Smed-Sörensen
39 [GO] 2022―Aug―23 Factors influencing the immune response over 15 months after SARS-CoV-2 infection: A longitudinal population-wide study in the Faroe Islands Maria Skaalum Petersen, Laura Pérez-Alós, Jose Juan Almagro Armenteros, Cecilie Bo Hansen, Jógvan Páll Fjallsbak, Sólrun Larsen, et al. (+12)
40 [GO] 2022―Aug―19 Persistent T-cell exhaustion in relation to prolonged pulmonary pathology and death after severe COVID-19: Results from two Norwegian cohort studies Marius Trøseid, Tuva B. Dahl, Jan C. Holter, Anders B. Kildal, Sarah L. Murphy, Kuan Yang, et al. (+22)
41 [GO] 2022―Aug―10 Incidence of SARS-CoV-2 infection among unvaccinated US adults during the Omicron wave Jennifer L. Alejo, Teresa PY Chiang, Jonathan Mitchell, Aura T. Abedon, Alexa A. Jefferis, William Werbel, et al. (+3)
42 [GO] 2022―Aug―09 Factors associated with severe or fatal clinical manifestations of SARS-CoV-2 infection after receiving the third dose of vaccine Giovanni Corrao, Matteo Franchi, Danilo Cereda, Francesco Bortolan, Olivia Leoni, Jose Jara, et al. (+2)
43 [GO] 2022―Jul―23 Increased mortality of patients with alcohol-related liver diseases during the COVID-19 pandemic in the United States Yee Hui Yeo, Biyao Zou, Ramsey Cheung, Mindie H. Nguyen
44 [GO] 2022―Jul―08 Vitamin D and COVID-19 - revisited Sreedhar Subramanian, George Griffin, Martin Hewison, Julian Hopkin, Rose Anny Kenny, Eamon Laird, et al. (+3)
45 [GO] 2022―Jul―04 Early SARS-CoV-2 associated acute transverse myelitis: A case for neurotropism? Irene F. Lu, Jack S. Cornish, Aadith Ashok, Siew Kar Chen, Eugene Athan, Andrew Hughes
46 [GO] 2022―May―25 Severe COVID-19 in people 55 and older during the first year of the pandemic in Sweden A. Rosengren, C. E. Lundberg, M. Söderberg, A. Santosa, J. Edqvist, M. Lindgren, et al. (+9)
47 [GO] 2022―May―25 Three doses of mRNA COVID-19 vaccine protects from SARS-CoV-2 infections in Japan Katsuyuki Hotta, Etsuji Suzuki, Eiki Ichihara, Katsuyuki Kiura
48 [GO] 2022―May―23 Randomized clinical trial of BCG vaccine in patients with convalescent COVID-19: Clinical evolution, adverse events, and humoral immune response Mehrsa Jalalizadeh, Keini Buosi, Franciele A. V. Dionato, Luciana S.B. Dal Col, Cristiane F. Giacomelli, Karen L. Ferrari, et al. (+8)
49 [GO] 2022―May―09 Adults hospitalized with breakthrough COVID-19 have lower mortality than matched unvaccinated adults Laura C. Myers, Patricia Kipnis, John Greene, Brian Lawson, Gabriel J. Escobar, Bruce H. Fireman, et al. (+2)
50 [GO] 2022―Apr―13 Detailed characterization of hospitalized patients infected with the Omicron variant of SARS-CoV-2 Errol Ozdalga, Neera Ahuja, Niraj Sehgal, Jason Hom, Yingjie Weng, Benjamin Pinsky, et al. (+2)
51 [GO] 2022―Apr―12 COVID-19 in Latin America and the Caribbean: Two years of the pandemic Alvaro Schwalb, Eleonora Armyra, Melissa Méndez-Aranda, César Ugarte-Gil
52 [GO] 2022―Apr―05 Variations in end-of-life care practices in older critically ill patients with COVID-19 in Europe Bernhard Wernly, Richard Rezar, Hans Flaatten, Michael Beil, Jesper Fjølner, Raphael Romano Bruno, et al. (+20)
53 [GO] 2022―Mar―15 1-year persistent symptoms and functional impairment in SARS-CoV-2 positive and negative individuals Mayssam Nehme, Olivia Braillard, François Chappuis, Delphine S. Courvoisier, Laurent Kaiser, Idris Guessous, et al. (+37)
54 [GO] 2022―Mar―07 Incidence and severity of COVID-19 in adults with and without HIV diagnosis Pontus Hedberg, Jan Vesterbacka, Ola Blennow, Catharina Missailidis, Piotr Nowak, Pontus Naucler
55 [GO] 2022―Feb―25 Respiratory dysfunction three months after severe COVID-19 is associated with gut microbiota alterations Beate Vestad, Thor Ueland, Tøri Vigeland Lerum, Tuva Børresdatter Dahl, Kristian Holm, Andreas Barratt-Due, et al. (+31)
56 [GO] 2022―Feb―23 Low anti-spike antibody levels correlate with poor outcomes in COVID-19 breakthrough hospitalizations Devang K. Sanghavi, Shivang Bhakta, Hani M. Wadei, Wendelyn Bosch, Jennifer B. Cowart, Rickey E. Carter, et al. (+12)
57 [GO] 2022―Feb―16 Acute odynophagia - a new symptom of COVID-19 during the SARS-CoV-2 Omicron variant wave in Sweden Krzysztof Piersiala, Lara Kakabas, Anna Bruckova, Magnus Starkhammar, Lars Olaf Cardell
58 [GO] 2022―Feb―03 The first wave of COVID-19 and concurrent social restrictions were not associated with a negative impact on mental health and psychiatric well-being Thorvardur Jon Love, Inga Wessman, Gauti Kjartan Gislason, Saemundur Rognvaldsson, Sigrun Thorsteinsdottir, Gudrun Asta Sigurdardottir, et al. (+6)
59 [GO] 2022―Jan―19 Post-Covid-19-vaccination adverse events and healthcare utilization among individuals with or without previous SARS-CoV-2 infection Francisco Tsz Tsun Lai, Lei Huang, Kuan Peng, Xue Li, Celine Sze Ling Chui, Eric Yuk Fai Wan, et al. (+4)
60 [GO] 2021―Dec―07 COVID-19 hospitalization is associated with pulmonary / diffusion abnormalities but not post-acute sequelae of COVID-19 severity Grace Y. Lam, A. Dean Befus, Ronald W. Damant, Giovanni Ferrara, Desi P. Fuhr, Cheryl R. Laratta, et al. (+5)
61 [GO] 2021―Dec―07 Impaired ACE2 glycosylation and protease activity lowers COVID-19 susceptibility in Gitelman's and Bartter's syndromes Giovanni Bertoldi, Verdiana Ravarotto, Luca Sgarabotto, Paul A Davis, Laura Gobbi, Lorenzo A Calò
62 [GO] 2021―Nov―15 Authors reply: Hypoalbuminemia in COVID-19 M. A. Wu, R. Colombo
63 [GO] 2021―Nov―15 Hypoalbuminemia in COVID-19 D. Lapenna
64 [GO] 2021―Nov―01 Effectiveness of REGEN-COV antibody cocktail against the B.1.617.2 (delta) variant of SARS-CoV-2: A cohort study Jagadeesh Kumar V, Sofia Banu, Mitnala Sasikala, Kishore V. L. Parsa, Divya Tej Sowpati, Rupali Yadav, et al. (+5)
65 [GO] 2021―Oct―29 Lp(a) and SARS-CoV-2: A conspiracy of two mysteries Byambaa Enkhmaa, Lars Berglund
66 [GO] 2021―Oct―08 Low anti-SARS-CoV-2 S antibody levels predict increased mortality and dissemination of viral components in the blood of critical COVID-19 patients María Martin-Vicente, Raquel Almansa, Isidoro Martínez, Ana P. Tedim, Elena Bustamante, Luis Tamayo, et al. (+34)
67 [GO] 2021―Sep―27 Long-term neuropsychiatric outcomes in COVID-19 survivors: A 1-year longitudinal study Raúl Méndez, Vicent Balanzá-Martínez, Sussy C. Luperdi, Itziar Estrada, Ana Latorre, Paula González-Jiménez, et al. (+5)
68 [GO] 2021―Aug―30 Low incidence of non-COVID-19 community respiratory viral infections amongst adults with hematological malignancies during the COVID-19 pandemic Jing Yuan Tan, Edwin Philip Conceicao, Liang En Wee, Heng Joo Ng, Indumathi Venkatachalam
69 [GO] 2021―Aug―30 Robust humoral and cellular immune responses and low risk for reinfection at least eight months following asymptomatic to mild COVID-19 Sebastian Havervall, Henry Ng, August Jernbom Falk, Nina Greilert-Norin, Anna Månberg, Ulrika Marking, et al. (+24)
70 [GO] 2021―Aug―26 Bowel ischemia as onset of COVID-19 in otherwise asymptomatic patients with persistently negative swab Paolo Zamboni, Daria Bortolotti, Savino Occhionorelli, Luca Traina, Luca Maria Neri, Roberta Rizzo, et al. (+2)
71 [GO] 2021―Aug―19 Neutrophil count predicts clinical outcome in hospitalized covid-19 patients: Results from the NOR-Solidarity trial Trine Kåsine, Anne Ma Dyrhol-Riise, Andreas Barratt-Due, Anders Benjamin Kildal, Inge Christoffer Olsen, Katerina Nezvalova Henriksen, et al. (+33)
72 [GO] 2021―Aug―05 Immunity to SARS-CoV-2 induced by infection or vaccination Xaquin Castro Dopico, Sebastian Ols, Karin Loré, Gunilla B. Karlsson Hedestam
73 [GO] 2021―Jul―16 Self-infection with speech aerosol may contribute to COVID-19 severity Poorna Kushalnagar, Carson C. Chow, Adriaan Bax
74 [GO] 2021―Jul―08 Antibody-dependent neutralizing capacity of the SARS-CoV-2 vaccine BNT162b2 with and without previous COVID-19 priming Cecilie Bo Hansen, Ida Jarlhelt, Rasmus Bo Hasselbalch, Sebastian Rask Hamm, Kamille Fogh, Mia Marie Pries-Heje, et al. (+14)
75 [GO] 2021―Jul―08 Body weight, body composition and the risk of SARS-CoV-2 infection in a large population-based sample Mélanie Deschasaux-Tanguy, Laurent Bourhis, Xavier Lamballerie, Fabrice Carrat, Mathilde Touvier
76 [GO] 2021―Jul―08 Immunogenicity of SARS-CoV-2 mRNA vaccine in solid organ transplant recipients Inge K. Holden, Claus Bistrup, Anna Christine Nilsson, Janne Fuglsang Hansen, Rozeta Abazi, Jesper Rømhild Davidsen, et al. (+4)
77 [GO] 2021―Jun―16 Mucormycosis and glucose-regulated protein 78 in COVID-19: amenable to statin treatment? Alpo Vuorio, Petri T. Kovanen
78 [GO] 2021―Jun―10 Truths and fakes in the smell terminology during the COVID-19 outbreak B. Arana-Fernández, A. Santamaría-Gadea, F. Mariño-Sánchez, J. Mullol
79 [GO] 2021―Jun―09 Mental health and quality of life in COVID-19 survivors: a needed discussion Sophia De Moraes De Medeiros, Raílla Vandresen, Elonir Gomes, Eliane Mazzuco
80 [GO] 2021―Jun―09 Breathing, speaking, coughing or sneezing: What drives transmission of SARS-CoV-2? V. Stadnytskyi, P. Anfinrud, A. Bax
81 [GO] 2021―Jun―07 Lipoprotein(a) and SARS-CoV-2 infections: susceptibility to infections, ischemic heart disease and thromboembolic events Silvia Di Maio, Claudia Lamina, Stefan Coassin, Lukas Forer, Reinhard Würzner, Sebastian Schönherr, Florian Kronenberg
82 [GO] 2021―Jun―04 Critical COVID-19 is associated with distinct leukocyte phenotypes and transcriptome patterns E. E. Christensen, M. J. Jørgensen, K. G. Nore, T. B. Dahl, K. Yang, T. Ranheim, et al. (+10)
83 [GO] 2021―May―28 What drives transmission of severe acute respiratory syndrome coronavirus 2? Jan Andersson
84 [GO] 2021―May―19 Seropositivity in blood donors and pregnant women during the first year of SARS-CoV-2 transmission in Stockholm, Sweden X. Castro Dopico, S. Muschiol, M. Christian, L. Hanke, D. J. Sheward, N. F. Grinberg, et al. (+8)
85 [GO] 2021―Apr―27 Half-year follow-up of patients recovering from severe COVID-19: Analysis of symptoms and their risk factors Y. F. Shang, T. Liu, J. N. Yu, X. R. Xu, K. R. Zahid, Y. C. Wei, et al. (+2)
86 [GO] 2021―Apr―19 Cause of death based on systematic postmortem studies in patients with positive SARS-CoV2 tissue PCR during the COVID-19 pandemic Elena S. Romanova, Valery V. Vasilyev, Galina Startseva, Vadim Karev, Margarita G. Rybakova, Pyotr G. Platonov
87 [GO] 2021―Apr―12 SARS-CoV-2 infections amongst personnel providing home care services for older persons in Stockholm, Sweden S. S. Hassan, Å. Seigerud, R. Abdirahman, L. S. Arroyo Mühr, S. Nordqvist Kleppe, E. Pin, et al. (+8)
88 [GO] 2021―Apr―06 Reply letter to: Inhibition of SARS-CoV-2 replication using calcineurin inhibitors: Are concentrations required clinically achievable? J. L. Gálvez-Romero, J. Deveaux-Homs, F. A. Real-Ramírez, O. Palmeros-Rojas, S. Pedraza-Sánchez
89 [GO] 2021―Apr―05 Psychophysical evaluations are important, usefulness and usability approaches to study the smell disorder related to COVID-19 Sven Saussez, Stéphane Hans, Carlos M. Chiesa-Estomba, Jerome R. Lechien
90 [GO] 2021―Mar―31 Cholestatic liver injury in COVID-19 is a rare and distinct entity and is associated with increased mortality Ben L. Da, Kelly Suchman, Nitzan Roth, Anam Rizvi, Maria Vincent, Arvind J. Trindade, et al. (+2)
91 [GO] 2021―Mar―13 Post-acute cognitive and mental health outcomes amongst COVID-19 survivors: early findings and a call for further investigation T. Vannorsdall, E. S. Oh
92 [GO] 2021―Mar―13 Impact of COVID-19 pandemic on the medical activities of the Directorate of Health and Hygiene, Vatican City State Massimo Ralli, Andrea Arcangeli, Paolo Maurizio Soave, Luigi Carbone, Lucia Ercoli, Fabio De-Giorgio
93 [GO] 2021―Mar―02 Arterial stiffness in acute COVID-19 and potential associations with clinical outcome Sebastian Schnaubelt, Julia Oppenauer, Daniel Tihanyi, Markus Mueller, Eduardo Maldonado-Gonzalez, Sara Zejnilovic, et al. (+9)
94 [GO] 2021―Feb―26 Inhibition of SARS-CoV-2 replication using calcineurin inhibitors: are concentrations required clinically achievable? X. Solanich, N. Padullés, J. Niubó, S. Videla, A. Antolí, G. Rocamora-Blanch, X. Corbella
95 [GO] 2021―Feb―10 Chest pain mimicking pulmonary embolism may be a common presentation of COVID-19 in ambulant patients without other typical features of infection Stephanie R Harrison, Joel RL Klassen, Charlie Bridgewood, Andrew Scarsbrook, Helena Marzo-Ortega, Dennis McGonagle
96 [GO] 2021―Feb―10 The development of preprints during the COVID-19 pandemic Andreas Älgå, Oskar Eriksson, Martin Nordberg
97 [GO] 2021―Feb―06 Short-term Neuropsychiatric Outcomes and Quality of Life in COVID-19 Survivors Raúl Méndez, Vicent Balanzá-Martínez, Sussy C. Luperdi, Itziar Estrada, Ana Latorre, Paula González-Jiménez, et al. (+9)
98 [GO] 2021―Feb―03 Pathophysiological Mechanisms and Management of Patients with Long-time Anosmia related to COVID-19 Jerome R. Lechien, Carlos M. Chiesa-Estomba, Stéphane Hans, Sven Saussez
99 [GO] 2021―Feb―03 Clinical Features of Patients who had two COVID-19 Episodes: A European Multicenter Case-series Jerome R. Lechien, Carlos M. Chiesa-Estomba, Thomas Radulesco, Justin Michel, Luigi A. Varia, Serge D. Le Bon, et al. (+6)
100 [GO] 2021―Jan―29 Tocilizumab in COVID-19 interstitial pneumonia G. Pomponio, A. Ferrarini, M. Bonifazi, M. Moretti, A. Salvi, A. Giacometti, et al. (+16)
101 [GO] 2021―Jan―27 Blood Group A Epitopes do not Facilitate Entry of SARS-CoV-2 Johannes Schetelig, Henning Baldauf, Sarah Wendler, Falk Heidenreich, Ruben Real, Martin Kolditz, et al. (+12)
102 [GO] 2021―Jan―19 Long-term recovery from COVID-19 anosmia: promising findings and unanswered questions Locatello Luca Giovanni, Oreste Gallo
103 [GO] 2021―Jan―19 Outcomes of COVID-19 Positive Acute Coronary Syndrome Patients; a multisource Electronic Healthcare Records Study from England Muhammad Rashid, Jianhua Wu, Adam Timmis, Nick Curzen, Sarah Clarke, Azfar Zaman, et al. (+7)
104 [GO] 2021―Jan―16 Assessment of Thirty-Day Readmission Rate, Timing, Causes, and Predictors after Hospitalization with COVID-19 Ilhwan Yeo, Seunghyup Baek, JoonHyuk Kim, Hadya Elshakh, Angelina Voronina, Man Si Lou, et al. (+4)
105 [GO] 2021―Jan―16 Increased vulnerability to Covid-19 in chronic kidney disease Nicholas Carlson, Karl-Emil Nelveg-Kristensen, Ellen Freese Ballegaard, Bo Feldt-Rasmussen, Mads Hornum, Anne-Lise Kamper, et al. (+2)
106 [GO] 2021―Jan―10 Hypoalbuminemia in COVID-19: assessing the hypothesis for underlying pulmonary capillary leakage M. A. Wu, T. Fossali, L. Pandolfi, L. Carsana, D. Ottolina, V. Frangipane, et al. (+10)
107 [GO] 2021―Jan―07 Prevalence and 6-month recovery of olfactory dysfunction: a multicentre study of 1363 COVID-19 patients J. R. Lechien, C. M. Chiesa-Estomba, E. Beckers, V. Mustin, M. Ducarme, F. Journe, et al. (+7)
108 [GO] 2020―Dec―29 Chronic rhinosinusitis is associated with prolonged SARS-CoV2 RNA shedding in upper respiratory tract samples: A case-control study B Recalde-Zamacona, A Tomás-Velázquez, A Campo, B Satrústegui-Alzugaray, M Fernández-Alonso, M Iñigo, et al. (+9)
109 [GO] 2020―Dec―20 Gastrointestinal Bleeding in Hospitalized COVID-19 Patients: A Propensity Score Matched Cohort Study Arvind J Trindade, Stephanie Izard, Kevin Coppa, Jamie S Hirsch, Calvin Lee, Sanjaya K Satapathy, et al. (+3)
110 [GO] 2020―Dec―11 The association between blood groups and COVID-19 infection: a study from the UK Biobank Jufen Zhang, Pierpaolo Pellicori, Rudolph Schutte, John G. Cleland
111 [GO] 2020―Dec―04 Cyclosporine A plus low-dose steroid treatment in COVID-19 improves clinical outcomes in patients with moderate to severe disease. A pilot study Jose Luis Galvez-Romero, Oscar Palmeros-Rojas, Fernando Antonio Real-Ramírez, Saúl Sánchez-Romero, Ramiro Tome-Maxil, María Patricia Ramírez-Sandoval, et al. (+18)
112 [GO] 2020―Dec―03 Tobacco smoking confers risk for severe COVID-19 unexplainable by pulmonary imaging J. Li, X. Long, Q. Zhang, X. Fang, N. Li, B. Fedorova, et al. (+4)
113 [GO] 2020―Dec―01 Direct oral anticoagulant use and risk of severe COVID-19 Benjamin Flam, Viktor Wintzell, Jonas F. Ludvigsson, Johan Mårtensson, Björn Pasternak
114 [GO] 2020―Nov―22 PCSK9 inhibitors for COVID-19: An opportunity to enhance the antiviral action of interferon in patients with hypercholesterolemia Alpo Vuorio, Petri T. Kovanen
115 [GO] 2020―Nov―19 ACE-Inhibitors, Angiotensin Receptor Blockers and Endothelial Injury in COVID-19 Simon Tetlow, Agnieszka Segiet-Swiecicka, Rebecca O’Sullivan, Sinead O’Halloran, Kelli Kalb, Charlotte Brathwaite-Shirley, et al. (+12)
116 [GO] 2020―Nov―09 Insights into Disparities Observed with COVID-19 John M. Carethers
117 [GO] 2020―Nov―03 A potential link between RAAS, obesity and atrial fibrillation in COVID-19 infection O. M. P. Jolobe
118 [GO] 2020―Oct―27 On the relationship between BCG coverage and national Covid-19 outcome: could “heterologous” herd immunity explain why some countries are better off? Maria Lerm
119 [GO] 2020―Oct―20 Thinking about tuberculosis in times of Covid-19 Rosarito Coronel Teixeira, Sarita Aguirre, Domingo Pérez Bejarano
120 [GO] 2020―Oct―20 Use of proton pump inhibitors and risk of adverse clinical outcomes from COVID-19: a meta-analysis C. S. Kow, S. S. Hasan
121 [GO] 2020―Oct―09 Clinical predictors of donor antibody titer and correlation with recipient antibody response in a COVID-19 convalescent plasma clinical trial Maria Lucia L. Madariaga, Jenna J. Guthmiller, Stephen Schrantz, Maud O. Jansen, Chancey Christensen, Madan Kumar, et al. (+28)
122 [GO] 2020―Oct―06 The Impact of Novel Coronavirus COVID-19 on Non-Communicable Disease Patients and Health Systems: A Review Andrew Y. Chang, Mark R. Cullen, Robert A. Harrington, Michele Barry
123 [GO] 2020―Sep―25 Elevated markers of gut leakage and inflammasome activation in COVID-19 patients with cardiac involvement H Hoel, L Heggelund, DH Reikvam, B Stiksrud, T Ueland, AE Michelsen, et al. (+9)
124 [GO] 2020―Sep―25 Reply to “High frequency of Antiphospholipid Antibodies in Critically ill COVID-19 patients: a Link with Hypercoagulability?” L. Suárez-Pérez, R. Coto-Hernández, C. Suárez-Cuervo, L. Caminal-Montero
125 [GO] 2020―Sep―23 Clinical characteristics and outcomes of immunosuppressed patients hospitalized with COVID-19: experience from London N. Vaid, M. Ardissino, T. A. N. Reed, J. Goodall, P. Utting, M. Miscampbell, et al. (+2)
126 [GO] 2020―Sep―22 Clinical characteristics and predictors of the duration of SARS-CoV-2 viral shedding in 140 healthcare workers W. Liu, Y. Liu, Z. Xu, T. Jiang, Y. Kang, G. Zhu, Z. Chen
127 [GO] 2020―Aug―03 Use of the IL-6R Antagonist Tocilizumab in Hospitalized COVID-19 Patients Krish Patel, Ted A. Gooley, Neil Bailey, Megumi Bailey, Livia Hegerova, Ami Batchelder, et al. (+21)
128 [GO] 2020―Aug―03 Tocilizumab shortens time on mechanical ventilation and length of hospital stay in patients with severe COVID-19: a retrospective cohort study. Johannes Eimer, Jan Vesterbacka, Anna-Karin Svensson, Bertil Stojanovic, Charlotta Wagrell, Anders Sönnerborg, Piotr Nowak
129 [GO] 2020―Jul―30 COVID-19 retinal microangiopathy as an in vivo biomarker of systemic vascular disease? M. F. Landecho, J. R. Yuste, E. Gándara, P. Sunsundegui, J. Quiroga, A. B. Alcaide, A. García-Layana
130 [GO] 2020―Jul―22 Cytokine storm syndrome in coronavirus disease 2019: A narrative review Y.-M. Gao, G. Xu, B. Wang, B.-C. Liu
131 [GO] 2020―Jul―11 The link between Vitamin D and Covid-19: distinguishing facts from fiction Peter Bergman
132 [GO] 2020―Jul―02 Perspective: Vitamin D deficiency and COVID-19 severity - plausibly linked by latitude, ethnicity, impacts on cytokines, ACE2, and thrombosis (R1) Jonathan M Rhodes, Sreedhar Subramanian, Eamon Laird, George Griffin, Rose Anne Kenny
133 [GO] 2020―Jul―01 Treatment with proton pump inhibitors increases the risk of secondary infections and ARDS in hospitalized patients with COVID-19: coincidence or underestimated risk factor? H. Luxenburger, L. Sturm, P. Biever, S. Rieg, D. Duerschmied, M. Schultheiss, et al. (+3)
134 [GO] 2020―Jun―30 Methylprednisolone added to tocilizumab reduces mortality in SARS-CoV-2 pneumonia: An observational study Francisco Sanz Herrero, Francesc Puchades Gimeno, Pilar Ortega García, Carolina Ferrer Gómez, María Dolores Ocete Mochón, Miguel García Deltoro
135 [GO] 2020―Jun―25 SARS-CoV-2 and biomimetics: What saves the planet will save our health P Stenvinkel, J Painer, PG Shiels, A Bansal, S Fereidouni, B Natterson-Horowitz, et al. (+2)
136 [GO] 2020―Jun―19 Beating the odds with systematic individualized care Nationwide prospective follow-up of all patients with COVID-19 in Iceland D Helgason, E Eythorsson, LB Olafsdottir, T Agustsson, S Ingvarsdottir, S Sverrisdottir, et al. (+5)
137 [GO] 2020―Jun―12 High Frequency of Antiphospholipid Antibodies in Critically-ill COVID-19 Patients: a Link with Hypercoagulability? Marc Pineton de Chambrun, Corinne Frere, Makoto Miyara, Zahir Amoura, Isabelle Martin-Toutain, Alexis Mathian, et al. (+2)
138 [GO] 2020―Jun―07 Viral Infections and Their Relationship with Catastrophic Antiphospholipid Syndrome: A Possible Pathogenic Mechanism of Severe COVID-19 Thrombotic Complications Claudia Mendoza-Pinto, Ricardo O. Escárcega, Mario García-Carrasco, David J.O. Bailey, Jose Luis Gálvez-Romero, Ricard Cervera
139 [GO] 2020―Jun―04 Older age and comorbidity are independent mortality predictors in a large cohort of 1305 COVID-19 patients in Michigan, United States Zaid Imam, Fadi Odish, Inayat Gill, Daniel O'Connor, Justin Armstrong, Aimen Vanood, et al. (+4)
140 [GO] 2020―May―28 Sex-based dimorphism in the SARS-CoV2 virulence L. Pala, F. Conforti
141 [GO] 2020―May―27 COVID-19 and Renin-Angiotensin system inhibition - role of angiotensin converting enzyme 2 (ACE2) - Is there any scientific evidence for controversy? Aneta Aleksova, Federico Ferro, Giulia Gagno, Chiara Cappelletto, Daniela Santon, Maddalena Rossi, et al. (+4)
142 [GO] 2020―May―26 Racial disparities in COVID-19 deaths reveal harsh truths about structural inequality in America A. Anyane-Yeboa, T. Sato, A. Sakuraba
143 [GO] 2020―Apr―30 Clinical and Epidemiological Characteristics of 1,420 European Patients with mild-to-moderate Coronavirus Disease 2019 Jerome R. Lechien, Carlos M. Chiesa-Estomba, Sammy Place, Yves Van Laethem, Pierre Cabaraux, Quentin Mat, et al. (+50)
144 [GO] 2020―Apr―29 COVID-19 diagnosis and management: a comprehensive review Giuseppe Pascarella, Alessandro Strumia, Chiara Piliego, Federica Bruno, Romualdo Del Buono, Fabio Costa, et al. (+2)
145 [GO] 2020―Apr―15 Carving out a place for internal medicine during COVID-19 epidemic in Italy Marco Vincenzo Lenti, Gino Roberto Corazza, Antonio Di Sabatino
146 [GO] 2020―Apr―03 Familial hypercholesterolemia and COVID-19: triggering of increased sustained cardiovascular risk Alpo Vuorio, Gerald F. Watts, Petri T. Kovanen
147 [GO] 2020―Mar―27 Early antiviral treatment contributes to alleviate the severity and improve the prognosis of patients with novel coronavirus disease (COVID-19) Jian Wu, Wei Li, Xiaowei Shi, Zhongming Chen, Bin Jiang, Jun Liu, et al. (+7)
 [1] 

147 Results       Page 1


[de][en]

Last change 2023―Oct―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.007 sec